AUG 18, 2026 · JOURNAL ARTICLE
An Outer Membrane Vesicle-Based Vaccine Combined with alb-Flt3L Promotes Durable Antitumor Immunity in HPV-Associated Cancer
Vaccines
A sound preclinical study in murine tumor models showing improved tumor control and survival with combination therapy, but requires clinical translation and confirmation before practice change.
Reported
Survival durationbeyond 60 days in more than half of treated…